Log in to save to my catalogue

A data science roadmap for open science organizations engaged in early-stage drug discovery

A data science roadmap for open science organizations engaged in early-stage drug discovery

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d7b4037ed6df47b49327448e7112d3fb

A data science roadmap for open science organizations engaged in early-stage drug discovery

About this item

Full title

A data science roadmap for open science organizations engaged in early-stage drug discovery

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2024-07, Vol.15 (1), p.5640-10, Article 5640

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The Structural Genomics Consortium is an international open science research organization with a focus on accelerating early-stage drug discovery, namely hit discovery and optimization. We, as many others, believe that artificial intelligence (AI) is poised to be a main accelerator in the field. The question is then how to best benefit from recent...

Alternative Titles

Full title

A data science roadmap for open science organizations engaged in early-stage drug discovery

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d7b4037ed6df47b49327448e7112d3fb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d7b4037ed6df47b49327448e7112d3fb

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-024-49777-x

How to access this item